BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23908987)

  • 1. Proceedings of the 7th International Cancer Vaccine Symposium, September 9-11, 2012, Florence, Italy.
    Ann N Y Acad Sci; 2013 May; 1284():1-86. PubMed ID: 23908987
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular immunotherapy of cancer. Proceedings of an international symposium. Racine, Wisconsin, October 30-November 1, 1986.
    Prog Clin Biol Res; 1987; 244():1-473. PubMed ID: 3659054
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer immunotherapy: current status and future directions.
    Ito F; Chang AE
    Surg Oncol Clin N Am; 2013 Oct; 22(4):765-83. PubMed ID: 24012398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abstracts of the Albert B. Sabin Vaccine Institute 4th Annual Colloquium on Cancer Vaccines and Immunotherapy. 6-10 March 2002, Walker's Cay, Bahamas.
    Cancer Immunol Immunother; 2003 Mar; 52 Suppl():S1-38. PubMed ID: 12656062
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer vaccines: unanswered questions. May 16, 2002, Phacilitate Spring Vaccine Forum, Cancer Vaccines, Paris, France.
    Fielding A
    Expert Rev Vaccines; 2002 Aug; 1(2):131-3. PubMed ID: 12901550
    [No Abstract]   [Full Text] [Related]  

  • 6. Whole tumor cell vaccines for glioma immunotherapy.
    Field CS; Hermans IF; Hunn MK
    Immunotherapy; 2016; 8(4):387-9. PubMed ID: 26973119
    [No Abstract]   [Full Text] [Related]  

  • 7. 1993 Keystone Symposium on Cellular Immunity and the Immunotherapy of Cancer. Proceedings. Taos, New Mexico, March 17-24, 1993.
    J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):79-161. PubMed ID: 7904181
    [No Abstract]   [Full Text] [Related]  

  • 8. Special issue: Biological response modifiers. Proceedings of an international symposium. 16-20 November 1992.
    Med Oncol Tumor Pharmacother; 1993; 10(1-2):1-86. PubMed ID: 7903111
    [No Abstract]   [Full Text] [Related]  

  • 9. The 1st Symposium on Local Cytokine Therapy of Cancer: Interleukin-2, Interferon and Related Cytokines. Hamburg, Germany, 29 April-1 May 1999. Abstracts.
    Anticancer Res; 1999; 19(3A):1995-2016. PubMed ID: 10498578
    [No Abstract]   [Full Text] [Related]  

  • 10. Composite peptide-based vaccines for cancer immunotherapy (Review).
    Yang J; Zhang Q; Li K; Yin H; Zheng JN
    Int J Mol Med; 2015 Jan; 35(1):17-23. PubMed ID: 25395173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges for cancer vaccine development.
    Tabi Z; Man S
    Adv Drug Deliv Rev; 2006 Oct; 58(8):902-15. PubMed ID: 16979786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches to immunoprevention and immunotherapy of neoplasms.
    Glushkov AN
    Russ J Immunol; 2002 Oct; 7(3):219-28. PubMed ID: 12674931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are peptide vaccines viable in combination with other cancer immunotherapies?
    Ohtake J; Sasada T
    Future Oncol; 2017 Aug; 13(18):1577-1580. PubMed ID: 28776424
    [No Abstract]   [Full Text] [Related]  

  • 14. IL-13 receptor-directed cancer vaccines and immunotherapy.
    Nakashima H; Husain SR; Puri RK
    Immunotherapy; 2012 Apr; 4(4):443-51. PubMed ID: 22512637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy Targeting WT1: Designing a Protocol for WT1 Peptide-Based Cancer Vaccine.
    Nishida S; Sugiyama H
    Methods Mol Biol; 2016; 1467():221-32. PubMed ID: 27417973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of adjuvants for immunotherapy.
    Circelli L; Tornesello M; Buonaguro FM; Buonaguro L
    Hum Vaccin Immunother; 2017 Aug; 13(8):1774-1777. PubMed ID: 28604160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fifth International Symposium on Bioluminescence and Chemiluminescence. Florence-Bologna, Italy, September, 1988. Proceedings.
    J Biolumin Chemilumin; 1990; 5(1):1-69. PubMed ID: 2316389
    [No Abstract]   [Full Text] [Related]  

  • 18. Current perspectives on immunotherapy.
    Weber JS
    Semin Oncol; 2014 Oct; 41 Suppl 5():S14-29. PubMed ID: 25438996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dendritic cell-based cancer immunotherapy].
    Aruga A
    Nihon Rinsho; 2010 Jun; 68(6):1107-10. PubMed ID: 20535963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives in cancer immunotherapy and immunomonitoring.
    Umansky V; Malyguine A; Shurin M
    Future Oncol; 2009 Sep; 5(7):941-4. PubMed ID: 19792962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.